DR. ANTONIS PRATSOS, M.D.

Plain English
This study looked at a new device called the Angio-Seal Evolution, which helps close up blood vessels after heart procedures. The researchers tested it on over 1,000 patients and found that it worked successfully 99.7% of the time, with major complications occurring in just 0.4% of cases. This is important because it shows that the automated device can safely and effectively close blood vessels, reducing the risk for patients after routine heart surgeries. Who this helps: Patients undergoing cardiac catheterization and intervention.

Plain English
This study looked at three methods for stopping bleeding after a heart procedure called percutaneous coronary intervention (PCI): a device called Angio-Seal VIP, another device called Perclose Proglide, and manual compression. The researchers found that Angio-Seal VIP was more effective; it took an average of 5.3 minutes to stop bleeding compared to 46.8 minutes for Perclose Proglide, and patients could walk sooner—about 4.4 hours after Angio-Seal VIP instead of 5.6 hours with Perclose Proglide. Overall, Angio-Seal VIP also provided more comfort for patients than manual compression. Who this helps: This helps patients undergoing PCI by reducing recovery time and discomfort.

Plain English
This research paper examines problems faced by patients with old saphenous vein grafts, specifically a condition called restenosis, where arteries narrow again after treatment. The study highlights that using stents has greatly improved the health outcomes for these patients, and future techniques like drug-coated stents could further reduce the chances of arteries narrowing again. This matters because it can lead to better long-term health for patients undergoing procedures for vein graft issues. Who this helps: Patients with saphenous vein grafts.